Smartphone applications (“apps”) with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers’ claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $4.96 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Ferrante di Ruffano, L., Takwoingi, Y., Dinnes, J., Chuchu, N., Bayliss, S.E., Davenport, C. et al. Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults. Cochrane Database Syst. Rev. 12, CD013186 (2019).
Ipsos-MORI. Technology tracker Q3. https://www.ipsos.com/sites/default/files/ct/publication/documents/2018-10/techtracker_q3_2018_final2.pdf (2018).
Flaten, H. K., St Claire, C., Schlager, E., Dunnick, C. A. & Dellavalle R. P. Growth of mobile applications in dermatology—2017 update. Dermatol Online J. 24, 13030/qt3hs7n9z6 (2018)
Freeman, K., Dinnes, J., Chuchu, N., Takwoingi, Y., Bayliss, S.E., Matin, R.N. et al. Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studies. BMJ 368, m127 (2020).
Udrea, A., Mitra, G.D., Costea, D., Noels, E.C., Wakkee, M., Siegel, D.M. et al. Accuracy of a smartphone application for triage of skin lesions based on machine learning algorithms. J. Eur. Acad. Dermatol. Venereol. 34, 648–655 (2020).
Deeks, J. J., Dinnes, J. & Williams, H. C. Sensitivity and specificity of SkinVision are likely to have been overestimated. J. Eur. Acad. Dermatol. Venereol. 34, e582–e583 (2020).
Cancer Research UK. Non-melanoma skin cancer incidence statistics (2016).
FDA. Mobile medical applications—guidance for industry and food and drug administration staff (Food and Drug Administration, Rockville MD, 2015).
Singh, K., Drouin, K., Newmark, L.P., Lee, J., Faxvaag, A., Rozenblum, R. et al. Many mobile health apps target high-need, high-cost populations, but gaps remain. Health Aff. (Millwood) 35, 2310–2318 (2016).
Torous, J. B., Chan, S.R., Gipson, S.Y.M.T., Kim, J.W., Nguyen, T.Q., Luo, J. et al. A hierarchical framework for evaluation and informed decision making regarding smartphone apps for clinical care. Psychiatr. Serv. 69, 498–500 (2018).
We would like to thank Prof. Jonathan Deeks and Prof. Hywel Williams for comments on an earlier version of the manuscript.
Ethics approval and consent to participate
Consent to publish
The authors declare no competing interests.
J.D. is supported by the National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham (grant reference No BRC-1215-20009). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Matin, R.N., Dinnes, J. AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation. Br J Cancer 124, 1749–1750 (2021). https://doi.org/10.1038/s41416-021-01302-3